TAIPY
Price:
$14
Market Cap:
$683.52B
Taisho Pharmaceutical Holdings Co., Ltd., through its subsidiaries, researches, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) drugs and prescription pharmaceutical products in Japan and internationally. It operates through Self-Medication Operation Group and Prescription Pharmaceutical Operation Group segments. The Self-Medication Operation Group segment offers OTC drugs, quasi-drugs, food products, and general medical and hygiene supplies, such as Lipovitan series of energy drinks; the Pabron series of cold remedies and sinus treatments; the RiUP series of hair re-growth treatment products; the Taisho Kampo series of gastrointestinal treatment products; the ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2021-01-08
Stock Exchange
PNK
Ticker
TAIPY
According to Taisho Pharmaceutical Holdings Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 446.34B. This represents a change of -503.70% compared to the average of -110560735669.31 of the last 4 quarters.
The mean historical Enterprise Value of Taisho Pharmaceutical Holdings Co., Ltd. over the last ten years is 272.39B. The current 446.34B Enterprise Value has changed 16.29% with respect to the historical average. Over the past ten years (40 quarters), TAIPY's Enterprise Value was at its highest in in the September 2018 quarter at 796.69B. The Enterprise Value was at its lowest in in the March 2023 quarter at -140431267920.47.
Average
272.39B
Median
493.28B
Minimum
-146415130659.47
Maximum
592.18B
Discovering the peaks and valleys of Taisho Pharmaceutical Holdings Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 40.85%
Maximum Annual Enterprise Value = 592.18B
Minimum Annual Increase = -115.17%
Minimum Annual Enterprise Value = -146415130659.47
Year | Enterprise Value | Change |
---|---|---|
2023 | -140428034419.52 | -4.09% |
2022 | -146415130659.47 | 40.85% |
2021 | -103953379700.16 | 21.47% |
2020 | -85578770642.50 | -115.17% |
2019 | 564.30B | 7.20% |
2018 | 526.38B | 8.37% |
2017 | 485.71B | -8.51% |
2016 | 530.91B | -10.35% |
2015 | 592.18B | 18.24% |
2014 | 500.85B | 7.68% |
The current Enterprise Value of Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-130265514926.38
5-year avg
17.59B
10-year avg
272.39B
Taisho Pharmaceutical Holdings Co., Ltd.’s Enterprise Value is less than Shionogi & Co., Ltd. (1.36T), greater than Vivesto AB (151.49M), greater than Acorda Therapeutics, Inc. (187.38M), greater than Pacira BioSciences, Inc. (1.21B), less than Haleon plc (0), greater than Dr. Reddy's Laboratories Limited (43.17B), less than Emergent BioSolutions Inc. (1.04T), greater than HUTCHMED (China) Limited (364.57M), greater than Viatris Inc. (2.91B), greater than Teva Pharmaceutical Industries Limited (31.70B), greater than Elanco Animal Health Incorporated (35.35B), greater than Catalent, Inc. (10.47B), greater than Mallinckrodt plc (15.68B), greater than null (2.67B),
Company | Enterprise Value | Market cap |
---|---|---|
1.36T | $10.56B | |
151.49M | $13.85M | |
187.38M | $821.03K | |
1.21B | $810.34M | |
0 | $43.68B | |
43.17B | $11.84B | |
1.04T | $513.67M | |
364.57M | $3.03B | |
2.91B | $15.96B | |
31.70B | $19.40B | |
35.35B | $6.60B | |
10.47B | $11.07B | |
15.68B | $4.52M | |
2.67B | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Taisho Pharmaceutical Holdings Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Taisho Pharmaceutical Holdings Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Taisho Pharmaceutical Holdings Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY)?
What is the 3-year average Enterprise Value for Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY)?
What is the 5-year average Enterprise Value for Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY)?
How does the current Enterprise Value for Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) compare to its historical average?